Company profile
Bonus Biogroup
Innovation ★ Tissue Engineering ★ Cell Therapy ★ Impact
- Industry
- Biotechnology Research
- Employees
- 42
- Headquarters
- Haifa, Matam Advanced Technology Park
- LinkedIn followers
- 6,042
- Office locations
- 1
Bonus Biogroup company summary
Bonus Biogroup is a company in the Biotechnology Research industry, headquartered in Haifa, Matam Advanced Technology Park. On LinkedIn the company has around 42 employees and 6,042 followers. Warmrank detected 32 technologies across 19 categories on bonus-bio.com, including Animate.css, Bootstrap, Facebook Pixel. Its listed specialties include Bone tissue engineering, Biotechnology, Adipose-derived stem cells, Mesenchymal stem cells, Critical gap bone fractures.
What technology does Bonus Biogroup use?
Warmrank detected 32 technologies on bonus-bio.com, last checked July 2026. Click any tool to see other companies that use it.
Facebook Pixel
Google Ads Conversion Tracking
Google Analytics
Hotjar
Linkedin Insight Tag
Google Ads
Linkedin Ads
Twitter AdsJavaScript libraries
Magnific Popup
jQuery
jQuery MigrateFont scripts
Font Awesome
Google Font APIMiscellaneous
HTTP/3
Open GraphUI frameworks
Animate.css
BootstrapAccessibility
HikeOrdersCDN
jsDelivrCMS
JoomlaHosting
GoDaddyJavaScript frameworks
MooToolsShow 8 more technologiesShow fewer technologies
Maps
LeafletProgramming languages
PHPSSL/TLS certificate authorities
Let's EncryptTag managers
Google Tag ManagerVideo players
YouTubeWeb frameworks
Helix UltimateWeb servers
LiteSpeedWebmail
Microsoft 365About Bonus Biogroup
Bonus BioGroup (TASE: BONS) is a clinical-stage Israeli biotechnology company engaged in the R&D of tissue-engineered and cell therapy products. Bonus CEO Dr. Shai Meretzki, one of Israel's most prominent biotech entrepreneurs, founded Bonus to build live tissues outside the body. He started with bones, developing BonoFill, the world's first tissue-engineered viable bone graft for treating severe bone defects currently under-treated by transplanting bone from another part of the body with considerable limitations. The active ingredients in BonoFill are mesenchymal cells isolated from the patient's adipose tissue. Using BonoFill, bones were successfully regenerated in already dozens of patients that recovered from years of disabilities. During the coronavirus outbreak, Bonus started developing MesenCure based on mesenchymal cells to treat life-threatening pneumonia and cytokine storm in severe Covid-19 patients. With excellent clinical results and established manufacturing capacity, Bonus strives to continue saving and improving patients' lives and becoming a world leader in regenerative medicine.
Specialties
Where is Bonus Biogroup located?
Bonus Biogroup lists 1 location.
Compare companies similar to Bonus Biogroup
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Bonus Biogroup bonus-bio.com | Biotechnology Research | 42 | - | Haifa, Matam Advanced Technology Park |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Bonus Biogroup
What does Bonus Biogroup do?
Bonus BioGroup (TASE: BONS) is a clinical-stage Israeli biotechnology company engaged in the R&D of tissue-engineered and cell therapy products. Bonus CEO Dr. Shai Meretzki, one of Israel's most prominent biotech entrepreneurs, founded Bonus to build live tissues outside the body. He started with bones, developing BonoFill, the world's first tissue-engineered viable bone graft for treating severe bone defects currently under-treated by transplanting bone from another part of the body with considerable limitations. The active ingredients in BonoFill are mesenchymal cells isolated from the patient's adipose tissue. Using BonoFill, bones were successfully regenerated in already dozens of patients that recovered from years of disabilities. During the coronavirus outbreak, Bonus started developing MesenCure based on mesenchymal cells to treat life-threatening pneumonia and cytokine storm in severe Covid-19 patients. With excellent clinical results and established manufacturing capacity, Bonus strives to continue saving and improving patients' lives and becoming a world leader in regenerative medicine.
What technology does Bonus Biogroup use?
Warmrank detected 32 technologies on bonus-bio.com, including Animate.css, Bootstrap, Facebook Pixel, Font Awesome, GoDaddy, Google Ads, Google Ads Conversion Tracking, Google Analytics.
How many employees does Bonus Biogroup have?
Bonus Biogroup has around 42 employees on LinkedIn.
Where is Bonus Biogroup headquartered?
Bonus Biogroup is headquartered in Haifa, Matam Advanced Technology Park.
Build a lead list from companies like Bonus Biogroup
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.